TMDX Jun 2024 50.000 call
| Previous Close | 84.95 |
| Open | 90.48 |
| Bid | 87.50 |
| Ask | 90.80 |
| Strike | 50.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 90.45 - 90.55 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 5 |
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 18, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 1,002 shares of its common stock and an aggregate of 657 restricted stock units to 1 employee, each as a material inducement for the employee's entry into employment with TransMedics. The grants
ZacksTransMedics (TMDX) Just Reclaimed the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
GuruFocus.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
Director Edward Basile of TransMedics Group Inc (NASDAQ:TMDX) sold 1,193 shares of the company on June 5, 2024, according to a recent SEC Filing.
